A previous study quantified soluble Aβ levels in the vitreous of 12 AMD patients vs. controls alongside levels of the receptor for advanced glycation end-products (RAGE), which serves as a receptor for Aβ. The gene discussed is AGER; the disease is age-related macular degeneration.